401 related articles for article (PubMed ID: 34515756)
1. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
Tsai HH; Chen YF; Yen RF; Lo YL; Yang KC; Jeng JS; Tsai LK; Chang CF
Brain; 2021 Dec; 144(11):3371-3380. PubMed ID: 34515756
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities: relationship to amyloid and tau burden.
Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
[TBL] [Abstract][Full Text] [Related]
3. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
[TBL] [Abstract][Full Text] [Related]
4. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
[TBL] [Abstract][Full Text] [Related]
5. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
6. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
[TBL] [Abstract][Full Text] [Related]
7. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
8. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
Pereira JB; Janelidze S; Smith R; Mattsson-Carlgren N; Palmqvist S; Teunissen CE; Zetterberg H; Stomrud E; Ashton NJ; Blennow K; Hansson O
Brain; 2021 Dec; 144(11):3505-3516. PubMed ID: 34259835
[TBL] [Abstract][Full Text] [Related]
9. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.
Schmitz TW; Soreq H; Poirier J; Spreng RN
J Neurosci; 2020 Feb; 40(9):1931-1942. PubMed ID: 31915256
[TBL] [Abstract][Full Text] [Related]
11. Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Tanaka M; Saito S; Inoue T; Satoh-Asahara N; Ihara M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183348
[TBL] [Abstract][Full Text] [Related]
12. Cerebral tau pathology in cerebral amyloid angiopathy.
Tsai HH; Liu CJ; Lee BC; Chen YF; Yen RF; Jeng JS; Tsai LK
Brain Commun; 2024; 6(2):fcae086. PubMed ID: 38638152
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
[TBL] [Abstract][Full Text] [Related]
14. Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study.
Wu C; Ma YH; Hu H; Zhao B; Tan L;
J Alzheimers Dis; 2023; 92(1):311-322. PubMed ID: 36744335
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
16. Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.
Franzmeier N; Rubinski A; Neitzel J; Kim Y; Damm A; Na DL; Kim HJ; Lyoo CH; Cho H; Finsterwalder S; Duering M; Seo SW; Ewers M;
Brain; 2019 Apr; 142(4):1093-1107. PubMed ID: 30770704
[TBL] [Abstract][Full Text] [Related]
17. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
[TBL] [Abstract][Full Text] [Related]
18. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
Wilson EN; Swarovski MS; Linortner P; Shahid M; Zuckerman AJ; Wang Q; Channappa D; Minhas PS; Mhatre SD; Plowey ED; Quinn JF; Zabetian CP; Tian L; Longo FM; Cholerton B; Montine TJ; Poston KL; Andreasson KI
Brain; 2020 Mar; 143(3):932-943. PubMed ID: 32065223
[TBL] [Abstract][Full Text] [Related]
19. Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy.
Abner EL; Elahi FM; Jicha GA; Mustapic M; Al-Janabi O; Kramer JH; Kapogiannis D; Goetzl EJ
FASEB J; 2020 Apr; 34(4):5967-5974. PubMed ID: 32157747
[TBL] [Abstract][Full Text] [Related]
20. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.
Reijmer YD; Fotiadis P; Martinez-Ramirez S; Salat DH; Schultz A; Shoamanesh A; Ayres AM; Vashkevich A; Rosas D; Schwab K; Leemans A; Biessels GJ; Rosand J; Johnson KA; Viswanathan A; Gurol ME; Greenberg SM
Brain; 2015 Jan; 138(Pt 1):179-88. PubMed ID: 25367025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
